Results for tag: "Transmucosal Drug Delivery"

Transmucosal drug delivery is a type of drug delivery system that involves the administration of drugs through mucous membranes, such as the oral, nasal, rectal, and vaginal mucosa. This method of drug delivery is advantageous because it allows for rapid absorption of drugs into the bloodstream, bypassing the digestive system and avoiding first-pass metabolism. Transmucosal drug delivery is often used for drugs that have poor oral bioavailability, such as peptides and proteins. Transmucosal drug delivery is distinct from transdermal drug delivery, which involves the administration of drugs through the skin. Transdermal drug delivery is advantageous because it allows for sustained drug release over a period of time. The transmucosal drug delivery market is composed of companies that develop and manufacture products for the delivery of drugs through mucous membranes. Examples of companies in this market include Aquestive Therapeutics, Inc., Biodelivery Sciences International, Inc., and Endo Pharmaceuticals, Inc. Show Less Read more